Pharmaceuticals & Healthcare
Dosage Products & Licensing
A growing portfolio of prescription generic, branded generic, biosimilar, and OTC dosage products across major therapeutic areas.
7
Core therapeutic segments served
1st
Site transfer of a Japanese innovator dosage form to India
Global
Government tenders and private-segment supply
Overview
A growing portfolio of prescription generic, branded generic, biosimilar and OTC dosage products, spanning major therapeutic areas and multiple regulated markets.
While India was still establishing itself in Japan's dosage-form business, Kyodo successfully completed a site transfer of a Japanese innovator's dosage-form production to one of India's leading pharmaceutical manufacturers. We have since developed and commercialized a range of generic dosage-form businesses that continue to this day, along with supporting a Japanese innovator in finding marketing partners in other countries.
Our contract manufacturing work spans hazardous and technically demanding chemistry carried out on the ground in India. We offer a growing portfolio of products, including prescription generic, branded generic, and biosimilar drugs, as well as OTC products, across therapeutic segments including CNS, infectious disease, respiratory and acute care, oncology, cardiovascular, and urology.
While India was still establishing itself in Japan's dosage-form business, Kyodo completed a site transfer of a Japanese innovator's production to one of India's leading manufacturers.
Therapeutic areas
CNS & Neurology
Central nervous system therapies across prescription and generic portfolios.
Infectious Disease
Anti-infective portfolios for regulated and emerging markets.
Respiratory & Acute Care
Respiratory and acute-care dosage forms.
Oncology
Oncology products including biosimilar opportunities.
Cardiovascular
Cardiovascular therapies for broad-population treatment.
Urology
Urology dosage forms across branded and generic lines.
01For rest-of-world markets
Kyodo is also active in the dosage-form business beyond Japan and India, including government tenders in Central and South Asia, and engagement with sourcing agencies across emerging markets in the MENA region. We continue to target expanded geographic coverage, backed by strengths in relationship management and market penetration at both ends of the supply chain.